Relationship between pulmonary exacerbations and daily physical activity in adults with cystic fibrosis

BMC Pulmonary Medicine

Volumn 15, Issue 1, 2015, Pages

  Savi, Daniela ^a,b   Simmonds, Nicholas ^b   Di Paolo, Marcello ^c   Quattrucci, Serena ^a   Palange, Paolo ^c,d   Banya, Winston ^b   Hopkinson, Nicholas S ^b   Bilton, Diana ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d Spencer Lorrillard Foundation   (Italy)

Author keywords

Cystic fibrosis; Daily physical activity; Gender difference; Pulmonary exacerbation rates

Indexed keywords

ACCELEROMETER; ADULT; ARTICLE; COHORT ANALYSIS; CYSTIC FIBROSIS; DISEASE EXACERBATION; ENERGY EXPENDITURE; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC EQUIVALENT; PHYSICAL ACTIVITY; SEX DIFFERENCE; TOTAL LUNG CAPACITY; ACCELEROMETRY; DISEASE COURSE; ENERGY METABOLISM; LUNG DIFFUSION CAPACITY; MIDDLE AGED; MOTOR ACTIVITY; PATHOPHYSIOLOGY; VITAL CAPACITY; YOUNG ADULT;

ACCELEROMETRY; ADULT; CYSTIC FIBROSIS; DISEASE PROGRESSION; ENERGY METABOLISM; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; METABOLIC EQUIVALENT; MIDDLE AGED; MOTOR ACTIVITY; PULMONARY DIFFUSING CAPACITY; SEX FACTORS; TOTAL LUNG CAPACITY; VITAL CAPACITY; YOUNG ADULT;

EID: 84949234059     PISSN: None     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/s12890-015-0151-7     Document Type: Article

References (30)

1. Ramsey BW, Davies J, McElvaney NG, Tullis E, Bell SC, Drevínek P, et al. VX08-770-102 Study Group. A CFTR potentiator in patients with cystic fibrosis and the G551D mutation. N Engl J Med. 2011;365:1663-72.
2. Cystic Fibrosis Foundation Patient Registry 2008. Annual Report to the Center Directors. Bethesda: Cystic Fibrosis Foundation; 2009.
3. Liou TG, Adler FR, Fitzsimmons SC, Cahill BC, Hibbs JR, Marshall BC. Predictive 5-year survivorship model of cystic fibrosis. Am J Epidemiol. 2001;153:345-52.
4. Wieboldt J, Atallah L, Kelly JL, Shrikrishna D, Gyi KM, Lo B, et al. Effect of acute exacerbations on skeletal muscle strength and physical activity in cystic fibrosis. J Cyst Fibros. 2012;11(3):209-15.
5. Britto MT, Kotagal UR, Hornung RW, Atherton HD, Tsevat J, Wilmott RW. Impact of recent pulmonary exacerbations on quality of life in patients with cystic fibrosis. Chest. 2002;121:64-72.
6. Robson M, Abbott J, Webb K, Dodd M, Walsworth-Bell J. A cost description of an adult cystic fibrosis unit and cost analyses of different categories of patients. Thorax. 1992;47:684-89.
7. Sanders DB, Bittner RC, Rosenfeld M, Hoffman LR, Redding GJ, Goss CH. Failure to recover to baseline pulmonary function after cystic fibrosis pulmonary exacerbation. Am J Respir Crit Care Med. 2010;182:627-32.
8. Sanders DB, Hoffman LR, Emerson J, Gibson RL, Rosenfeld M, Redding GJ, et al. Return of FEV1 after pulmonary exacerbation in children with cystic fibrosis. Pediatr Pulmonol. 2010;45:127-34.
9. Waters V, Stanojevic S, Atenafu EG, Lu A, Yau Y, Tullis E, et al. Effect of pulmonary exacerbations on long-term lung function decline in cystic fibrosis. Eur Respir J. 2012;40(1):61-6.
10. de Boer K, Vandemheen KL, Tullis E, Doucette S, Fergusson D, Freitag A, et al. Exacerbation frequency and clinical outcomes in adult patients with cystic fibrosis. Thorax. 2011;66(8):680-85.
11. Baldwin DR, Hill AL, Peckam DG, Knox AJ. Effect of addition of exercise to chest physiotherapy on sputum expectoration and lung function in adults with cystic fibrosis. Respir Med. 1994;88:49-53.
12. Wilkes DL, Schneiderman JE, Nguyen T, Heale L, Moola F, Ratjen F, et al. Exercise and physical activity in children with cystic fibrosis. Paediatric Respir Rev. 2009;10(3):105-9.
13. Burtin C, Van Remoortel HV, Vrijsen B, Langer D, Colpaert K, Gosselink R, et al. Impact of exacerbations of cystic fibrosis on muscle strength. Respiratory Research. 2013;14:46.
14. van de Weert-van Leeuwen PB, Arets HG, van der Ent CK, Beekman JM. Infection, inflammation and exercise in cystic fibrosis. Respir Res. 2013;14:32.
15. Savi D, Quattrucci S, Internullo M, De Biase RV, Calverley PM, Palange P. Measuring habitual physical activity in adults with cystic fibrosis. Respiratory Medicine. 2013;107(12):1888-94.
16. Troosters T, Langer D, Vrijsen B, Segers J, Wouters K, Janssens W, et al. Skeletal muscle weakness, exercise tolerance and physical activity in adults with cystic fibrosis. Eur Respir J. 2009;33:99-106.
17. Dwyer TJ, Elkins MR, Bye PTP. The role of exercise in maintaining health in cystic fibrosis. Current Opinion in Pumonary Medicine. 2011;17:455-60.
18. Ward N, White D, Rowe H, Stiller K, Sullivan T. Physical activity levels of patients with cystic fibrosis hospitalised with an acute respiratory exacerbation. Respiratory Medicine. 2013;107(7):1014-20.
19. Goss CH, Burns JL. Exacerbations in cystic fibrosis. 1: epidemiology and pathogenesis. Thorax. 2007;62:360-7.
20. Flume PA, Mogayzel Jr PJ, Robinson KA, Goss CH, Rosenblatt RL, Kuhn RJ, et al. Clinical Practice Guidelines for Pulmonary Therapies Committee. Clinical Practice Guidelines for Pulmonary Therapies Committee. Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations. Am J Respir Crit Care Med. 2009;180:802-8.
21. Crapo RO, Morris AH, Gardner RM. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis. 1981;123:659-64.
22. Haskell WL, Lee IM, Pate RR, Powell KE, Blair SN, Franklin BA, et al. American College of Sports Medicine; American Heart Association. American College of Sports Medicine; American Heart Association: Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and American Heart Association. Circulation. 2007;116:1081-93.
23. Dwyer T, Alison JA, McKeough Z, Elkins MR, Bye PT. Evaluation of the SenseWear activity monitor during exercise in cystic fibrosis and in health. Respir Med. 2009;103:1511-7.
24. Cox NS, Alison JA, Button BM, Wilson JW, Morton JM, Dowman LM, et al. Validation of a multi-sensor armband during free-living activity in adults with cystic fibrosis. Journal of Cystic Fibrosis. 2014;13:347-50.
25. Jarad NA, Giles K. Risk factors for increased need for intravenous antibiotics for pulmonary exacerbations in adult patients with cystic fibrosis. Chron Respir Dis. 2008;5(1):29-33.
26. Schneiderman-Walker J, Wilkes DL, Strug L, Lands LC, Pollock SL, Selvadurai HC, et al. Sex differences in habitual physical activity and lung function decline in children with cystic fibrosis. J Pediatr. 2005;147(3):321-6.
27. Selvadurai HC, Blimkie CJ, Cooper PJ, Mellis CM, Van Aspern PP. Gender differences in habitual activity in children with cystic fibrosis. Arch Dis Child. 2004;89:928-33.
28. Cox NS, Alison JA, Holland AE. Interventions to promote physical activity in people with cystic fibrosis. Paediatric Respiratory Reviews. 2014;15:237-9.
29. Hebestreit H, Kieser S, Rudiger S, et al. Physical activity is independently related to aerobic capacity in cystic fibrosis. European Respiratory Journal. 2006;28:734-9.
30. Gimeno-Santos E, Frei A, Steurer-Stey C, de Batlle J, Rabinovich RA, Raste Y, et al. PROactive consortium. Determinants and outcomes of physical activity in patients with COPD: a systematic review. Thorax. 2014;69(8):731-9.